Literature DB >> 25511743

Natural killer cells: the journey from puzzles in biology to treatment of cancer.

Lakshmi Narendra Bodduluru1, Eshvendar Reddy Kasala2, Rajaram Mohan Rao Madhana2, Chandra Shaker Sriram2.   

Abstract

Natural Killer (NK) cells are innate immune effectors that are primarily involved in immunosurveillance to spontaneously eliminate malignantly transformed and virally infected cells without prior sensitization. NK cells trigger targeted attack through release of cytotoxic granules, and secrete various cytokines and chemokines to promote subsequent adaptive immune responses. NK cells selectively attack target cells with diminished major histocompatibility complex (MHC) class I expression. This "Missing-self" recognition by NK cells at first puzzled researchers in the early 1990s, and the mystery was solved with the discovery of germ line encoded killer immunoglobulin receptors that recognize MHC-I molecules. This review summarizes the biology of NK cells detailing the phenotypes, receptors and functions; interactions of NK cells with dendritic cells (DCs), macrophages and T cells. Further we discuss the various strategies to modulate NK cell activity and the practice of NK cells in cancer immunotherapy employing NK cell lines, autologous, allogeneic and genetically engineered cell populations.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adoptive cell transfer; Cancer; Immunotherapy; NK cells

Mesh:

Substances:

Year:  2014        PMID: 25511743     DOI: 10.1016/j.canlet.2014.12.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.

Authors:  Sophie M Poznanski; Nicole G Barra; Ali A Ashkar; Jonathan D Schertzer
Journal:  Inflamm Res       Date:  2018-07-31       Impact factor: 4.575

2.  Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy.

Authors:  Tadahiko Yanagita; Yoji Murata; Daisuke Tanaka; Sei-Ichiro Motegi; Eri Arai; Edwin Widyanto Daniwijaya; Daisuke Hazama; Ken Washio; Yasuyuki Saito; Takenori Kotani; Hiroshi Ohnishi; Per-Arne Oldenborg; Noel Verjan Garcia; Masayuki Miyasaka; Osamu Ishikawa; Yae Kanai; Takahide Komori; Takashi Matozaki
Journal:  JCI Insight       Date:  2017-01-12

Review 3.  Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy.

Authors:  Huang Zhu; Yi-Shin Lai; Ye Li; Robert H Blum; Dan S Kaufman
Journal:  Stem Cells       Date:  2018-01-03       Impact factor: 6.277

Review 4.  Medications for Multiple Sclerosis and Risk of Malignancy: What Next?

Authors:  Daniel B Horton; Anthony T Reder
Journal:  Neurotherapeutics       Date:  2021-08-18       Impact factor: 6.088

5.  Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.

Authors:  David L Hermanson; Laura Bendzick; Lee Pribyl; Valarie McCullar; Rachel Isaksson Vogel; Jeff S Miller; Melissa A Geller; Dan S Kaufman
Journal:  Stem Cells       Date:  2015-12-06       Impact factor: 6.277

Review 6.  The immune system in cancer metastasis: friend or foe?

Authors:  Louise M E Janssen; Emma E Ramsay; Craig D Logsdon; Willem W Overwijk
Journal:  J Immunother Cancer       Date:  2017-10-17       Impact factor: 13.751

7.  M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.

Authors:  Magdalena Jarosz-Biej; Natalia Kamińska; Sybilla Matuszczak; Tomasz Cichoń; Jolanta Pamuła-Piłat; Justyna Czapla; Ryszard Smolarczyk; Daria Skwarzyńska; Klaudia Kulik; Stanisław Szala
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

Review 8.  Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

Authors:  Leonard Angka; Sarwat T Khan; Marisa K Kilgour; Rebecca Xu; Michael A Kennedy; Rebecca C Auer
Journal:  Int J Mol Sci       Date:  2017-08-17       Impact factor: 5.923

Review 9.  Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Cell Oncol (Dordr)       Date:  2018-02-22       Impact factor: 6.730

Review 10.  Neutrophils in Cancer: Two Sides of the Same Coin.

Authors:  Eileen Uribe-Querol; Carlos Rosales
Journal:  J Immunol Res       Date:  2015-12-24       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.